[EXCLUSIVE] Lobbying Disclosures in the US: How Big Pharma Fought the TRIPS Waiver & is Pushing for Strong Intellectual Property Protection in the Pandemic Agreement

Newsletter Edition #234 [The Files In-Depth]

Hi,

If you have trouble understanding why international diplomacy is a vastly unequal field, or in mapping the scale of corporate power in determining public health outcomes, read our edition today.

…